乾漆이 위암세포의 활성, 세포사멸 및 세포주기관련 유전자 발현에 미치는 영향

키워드

참고문헌 (44)

1. 통계청, "2004년도 사망원인통계결과", pp.13~15 (2005)
2. 김 병, "위암의 동서의학적 진치개황", 17(2), pp.100~116 (1996)
3. 윤성우, "위암이 동의학 및 동서의 결합치료에 관한 문헌적 고찰", pp.177~192 (1996)
4. 김성훈, "韓醫學界의 癌硏究動向과 硏究戰略에 대한 연구", 19(1), pp.470~499 (1998)
5. 김동희, "抗癌劑 및 放射線 副作用에 대한 韓方療法", 9, pp.239~264 (1994)
6. 안덕균, "한국본초도감", pp.~729 (2003), 교학사
7. Jung, N.C, "Biological activity of urushiol and flavonoids from Lac tree" (1998), Chonnam National University
8. Lee, J.C.,, "Ethanol eluted extract of Rhus verniciflua Stokes showed both antioxidant and cytotoxic effects on mouse thymocytes depending on the dose and time of the treatment Journal of Biochemistry and Molecular Biology", pp.250~258 (2001)
9. Lee, J.C.,, "Identification of Rhus verniciflua Stokes compounds that exhibit free radical scavenging and anti-apoptotic properties" (2002)
10. Kitts, D.D.,, "TAntitumorigenic and cytotoxic properties of an ethanol extract derived from Rhus verniciflua Stokes Journal of Toxicology and Environmental Health Part A", pp.357~371 (2001)
11. Lee, J.C.,, "Ethanol-eluted extract of Rhus verniciflua stokes inhibits cell growth and induces apoptosis in human lymphoma cells", pp.337~343 (2003)
12. Lee, J.C.,, "Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells", pp.1383~1388 (2004)
13. Meier, P.,, "Apoptosis in development", pp.796~801 (2000), Finch
14. Jonstone, R.W, "Apoptosis: a link between cancer genetics and chemotherapy", pp.153~164 (2002)
15. Green, D.R, "Apoptotic pathways: paper wraps stone blunts scissors", pp.1~4 (2000)
16. Kothakota, S.,, "Caspase- 3-generated fragment of gelsolin: Effector of morphological change in apoptosis.", pp.294~298 (1997)
17. Nunez, G.,, "The proteases of the apoptotic pathway", and i(hara), pp.3237~3245 (1998)
18. Adams, J.M, "The Bcl-2 protein family: arbiters of cell survival", pp.1322~1326 (1998)
19. Atan, G.,, "Bcl-2 family members and the mitochondria in apoptosis" (1999)
20. Nasmyth, K, "putting the cell cycle in order", pp.1643~1645 (1996)
21. Sherr, C.J, "positive and negative regulators of G1-phase progression", pp.1501~1121 (1999)
22. Polyak, "links transforming growth factor beta and contact inhibition to cell cycle arrest", pp.9~22 (1994), a cyclin Cdk inhibitor
23. Toyoshima, "a novel inhibitor of G1 cyclin-Cdk protein kinase activity is related to p21", pp.67~74 (1994)
24. Coats, S.,, "Requirement of p27kip1 for restriction point control of the fibroblast cell cycle", pp.877~880 (1996)
25. Coqueret, O, "New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment Trends", pp.65~70 (2003)
26. Elledge, S.J, "The role of protein stability in the cell cycle and cancer" (1998)
27. Pagano, M.,, "Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27", pp.682~685 (1995)
28. Schulman, B.A.,, "Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex", pp.381~386 (2000)
29. Carrano, A.C.,, "SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27" (1999)
30. Sutterluty, H.,, "p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells", pp.207~214 (1999)
31. Tsvetkov, L.M.,, "ubiquitination and degradation is regulated by the SCF complex through phosphorylated Thr187 in p27", pp.661~664 (1999)
32. Nakayama, K.I.,, "Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1", pp.853~860 (2001)
33. Masuda, T.A.,, "Clinical and biological significance of S-phase kinase-associated protein 2 gene expression in gastric carcinoma modulation of malignant phenotype by Skp2 overexpression", pp.3819~3825 (2002)
34. Nevins, "a link between the Rb tumor suppressor protein and viral oncoproteins", pp.424~429 (1992)
35. and Kaelin, "E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product", pp.6914~6918 (1993)
36. Helin, "Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein", pp.6501~6508 (1993)
37. Humbert, P.O.,, "E2F3 is critical for normal cellular proliferation", pp.690~703 (2000)
38. Dalton,S, "Cell cycle regulation of the human cdc2 gene", 11, pp.1797~1804 (1992)
39. Sheaff, R.J.,, "Cyclin E-CDK2 is a regulator of p27Kip1", pp.1464~1478 (1997)
40. Vlach, J.,, "Phosphorylation- dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1", pp.5334~5344 (1997)
41. Lloyd, R.V.,, "a multifunctional cyclin dependent kinase inhibitor with prognostic significance in human cancers", pp.313~323 (1999)
42. Stacy, W.B., "p27 as a target for cancer therapeutics", pp.111~115 (2003)
43. Masuda, T.A.,, "Clinical and biological significance of S-phase kinase-associated protein 2 gene expression in gastric carcinoma modulation of malignant phenotype by Skp2 overexpression", pp.3819~3825 (2002)
44. Masuda, T.A.,, "Clinical and biological significance of S-phase kinase-associated protein 2 gene expression in gastric carcinoma modulation of malignant phenotype by Skp2 overexpression", pp.3819~3825 (2002)

관련 논문AI추천